Have you entered in the 2023 Innovation Award?


Min Read

In this blog:

  • We look back on past CiteAb Innovation Award winners
  • What innovation did these winners show?
  • How do I enter in this year’s Innovation Award?

For the last few years, we have called for suppliers and researchers to let us know about an innovative product making an impact in the life sciences through the CiteAb Awards.

The CiteAb Awards celebrate the, often unsung, successes of individuals and suppliers in the research reagent sector, and how this success helps accelerate scientific progress.

The Innovation Award category puts a spotlight on a product, launched in the past year for any reagent type or instrument, which has solved an issue in the field or addressed a gap in the market. 

The winner of this award will be decided by a panel of expert judges from academia, pharma, and publishing worlds. 

Andrew Chalmers, CiteAb CEO, said of the Innovation Award: ‘This award is one of our favourites, as each year we discover some really cool products that are advancing research and enabling exciting new discoveries to be made. We’re really looking forward to seeing all the new innovations that have taken place over the past year.’

Putting the spotlight on previous Innovation Award winners

  • 2022 Innovation Award

Taking home the Innovation Award in 2022 was Abcam with their recombinant multiclonal range. They identified a key issue: researchers require the specificity of monoclonals for their work, but still need a larger detection signal which polyclonals can provide. The winning product offered a solution.

Their recombinant multiclonal range consists of a mixture of monoclonals produced recombinantly, targeting different epitopes on the same target. This helps to generate a larger signal for experimental work.

  • 2020 Innovation Award

In 2020, the Innovation Award went to Millipore Sigma with their ZooMAb® Recombinant Antibodies. This new product showcased innovation through improvements to antibody scalability, shipping and stability. 

This was achieved through a developed proprietary expression system for antibody production, coupled with ensuring antibodies were sodium azide free and lyophilized. 

  • Looking further back

In 2019, the award went to Miltenyi for their REAlease releasable antibodies, and in 2018 Diagenode won with their Automated ChIPmentation technology. You can read more about these winning products on our Awards website.

How can I nominate for an Innovation Award?

Simply head to the awards website and complete the short nomination form to be in with a chance of winning the 2023 Innovation Award. Entries will be judged by an impressive panel of scientists and innovators. 

The entry form requires a <300 word description of how this product has created or will create impact and what challenges it solves in research. You will gain no advantage by submitting many nominations, instead we will be judging the quality and content of individual nominations.

Be sure to describe how the product showcases innovation and how it will make a difference to research progress. Include details on when the product was launched to ensure you are eligible. Entry in the CiteAb Awards is free of charge.

Why should you submit a nomination for the Innovation Award?

This category presents a great opportunity to celebrate a product that is going to provide value to researchers around the world. 

Entering enables you to showcase the product’s impact, let researchers know why it’s innovative, and receive all the benefits of being named a CiteAb Award winner. The CiteAb Awards are long standing industry awards, and are promoted widely.

You are able to enter a product your own company has produced, or a product you’ve used or have come across from another company. 

So, head over to the awards website and tell us all about your innovations!

  • Alicia and the CiteAb team
About the author

Join thousands of people who already enjoy the CiteAb newsletter

To keep up to date with the latest developments to our search engine, news from our life science market data analysis and improvements to our citation provision.